Back

RNAi therapeutics: revolutionising cardiovascular management

31 August 2025 (15:20 - 15:30)
Organised by: Logo
Congress Presentation Part of: RNAi therapeutics: changing the future landscape in ATTR-CM management Cardiac Amyloidosis Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Sarah Cuddy

Brigham and Women's Hospital, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
Welcome and introductions
Doctor E. Gonzalez Lopez (Madrid, ES)
Presentation thumbnail
Vutrisiran in ATTR-CM: transforming outcomes with precision medicine
Doctor C. Morbach (Wuerzburg, DE)
Presentation thumbnail
Ask the experts – panel discussion and audience Q&A

Access the full session

Session thumbnail
RNAi therapeutics: changing the future landscape in ATTR-CM management

The Event

Event poster

ESC Congress 2025

31 August 2025 15:20 CET
You may be interested in
thumbnail
Congress Session
New frontiers in heart failure therapies
19 May 2025
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials
27 August 2021
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Presentation
Effect of RNAi therapeutics patisiran and vutrisiran on orthostatic hypotension due to dysautonomia in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources